Orange Biomed announced a major milestone on its path to bringing a pocket-sized A1C analysis device to the market.

A multicenter collaboration of Danish researchers reports that once-weekly semaglutide for 30 weeks lowered blood sugar ...

It is over half a century since haemoglobin A1c (HbA1c) was recognised by medical professionals; the importance of HbA1c to the long term health of people with diabetes was clearly demonstrated in ...

Please provide your email address to receive an email when new articles are posted on . Women younger than 50 years without diabetes have an HbA1c 1.6 mmol/mol lower than men. Researchers suggest ...

Please provide your email address to receive an email when new articles are posted on . Adults with obesity plus type 2 diabetes had the largest HbA1c reduction when they exercised during the ...

A study analyzing the PIONEER trial data claims that orally administered semaglutide is highly effective in reducing glycated hemoglobin (HbA1c) and body weight in type 2 diabetes patients. The study ...

Orforglipron significantly reduced HbA1c levels by 1.3% (3mg), 1.6% (12mg), and 1.5% (36mg) compared with 0.1% in the placebo arm. Orforglipron, a once-daily glucagon-like peptide-1 (GLP-1) receptor ...